Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05229640Not ApplicableWithdrawn
Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis
CF - Cystic FibrosisCystic Fibrosis Liver DiseaseCystic Fibrosis-related Diabetes
PrincipalinvestigatorStart date: 2022-03-31

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Dartmouth-Hitchcock Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Katherine Kutney, MD

University Hospitals Cleveland Medical Center

Related
1 trials

Shared therapeutic areas:

Cystic Fibrosis Liver DiseaseCystic Fibrosis-related Diabetes
Similarity Score20%

Susanne D Poulsen, MD DMSc

Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital Rigshospitalet, University of Copenhagen

Related
1 trials

Shared therapeutic areas:

Cystic Fibrosis-related Diabetes
Similarity Score10%

Ticiana C Rodrigues, Doctor

Hospital de Clinicas de Porto Alegre

Related
1 trials

Shared therapeutic areas:

Cystic Fibrosis-related Diabetes
Similarity Score10%

Ashley R Deschamp, MD

University of Nebraska

Related
1 trials

Shared therapeutic areas:

Cystic Fibrosis-related Diabetes
Similarity Score10%

Averell Sherker, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
11 trials

Shared therapeutic areas:

Cystic Fibrosis Liver Disease
Similarity Score10%

Katie Larson Ode, MD

University of Iowa

Related
2 trials

Shared therapeutic areas:

Cystic Fibrosis-related Diabetes
Similarity Score10%

Kevin J Scully, MB BCh BAO

Rhode Island Hospital

Related
1 trials

Shared therapeutic areas:

Cystic Fibrosis-related Diabetes
Similarity Score10%

Tacjana Pressler, MD

CF Centre Copenhagen University Hospital Rigshospitalet

Related
1 trials

Shared therapeutic areas:

Cystic Fibrosis-related Diabetes
Similarity Score10%

Amir Moheet, MBBS

University of Minnesota

Related
1 trials

Shared therapeutic areas:

Cystic Fibrosis-related Diabetes
Similarity Score10%

Melissa S Putman, MD

Massachusetts General Hospital

Related
1 trials

Shared therapeutic areas:

Cystic Fibrosis-related Diabetes
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05229640Not ApplicablePrincipalInvestigator

Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis

CF - Cystic FibrosisCystic Fibrosis Liver DiseaseCystic Fibrosis-related Diabetes
Withdrawn

All 1 trials loaded